-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
KalVista Pharmaceuticals, Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from Q2 2018 to Q2 2023.
- KalVista Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending July 31, 2023 was $204K, a 21.4% increase year-over-year.
- KalVista Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $151M, a 159% increase from 2022.
- KalVista Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $58.1M, a 3576% increase from 2021.
- KalVista Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $1.58M, a 99.3% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)